Upper Saddle River, NJ, United States of America

Nitin Krishnaji Damle

This inventor holds 28 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Bristol-Myers Squibb Compnay, Wyeth Holdings Corporation, Wyeth. Active years: 1995-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nitin Krishnaji Damle. Retrieved from https://idiyas.com/inventor/nitin-krishnaji-damle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 11)

% Patents Active = 78.6

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 5.1

ph-index = 17

Forward Citations = 1,628(Granted Patents)

Location History:

Bellevue, WA (US) (1998)
Hopewell, NJ (US) (1998 - 1999)
Monmont Junction, NJ (US) (2005)
Renton, WA (US) (1995 - 2006)
Monmount Junction, NJ (US) (2007)
Upper Saddle River, NJ (US) (2006 - 2018)
Berwyn, PA (US) (2019 - 2022)

Company Filing History:

19 out of 3,745

Bristol-Myers Squibb Compnay

patents

4 out of 113

Wyeth Holdings Corporation

Asana Biosciences, LLC

patents

Years Active: 1995-2022

Loading Chart...

Areas of Expertise:

Protein-Polymer-Drug Conjugates

Anti-5T4 Antibodies

Calicheamicin Derivative

CTLA4 Receptor

Soluble CTLA4 Molecules

Cell Adhesion

B7 Binding Molecules

Chimeric Receptors

Immune Response Regulation

Fusion Proteins

CD28 Receptor

Cancer Treatment

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11434278 - Protein-polymer-drug conjugates (2022-09-06),

2. 10316080 - Protein-polymer-drug conjugates (2019-06-11),

3. 9902771 - Anti-5T4 antibodies and uses thereof (2018-02-27),

4. 9351986 - Calicheamicin derivative-carrier conjugates (2016-05-31),

5. 8835611 - Calicheamicin derivative-carrier conjugates (2014-09-16),

6. 8759495 - Anti-5T4 antibodies and uses thereof (2014-06-24),

7. 8747857 - Calicheamicin derivative-carrier conjugates (2014-06-10),

8. 8153768 - Calicheamicin derivative-carrier conjugates (2012-04-10),

9. 8044178 - Anti-5T4 antibodies and uses thereof (2011-10-25),

10. 7572772 - Soluble CTLA4 mutant molecules (2009-08-11),

11. 7311910 - Methods for treating cancer and infectious disease by blocking CTLA4-B7 interactions (2007-12-25),

12. 7105166 - Soluble CTLA4 mutant molecules and uses thereof (2006-09-12),

13. 7070776 - Methods for blocking binding of CD28 receptor to B7 (2006-07-04),

14. 6887471 - Method to inhibit T cell interactions with soluble B7 (2005-05-03),

15. 6830937 - Method for generating and identifying antibodies directed against a B7 (2004-12-14),

Title: Nitin Krishnaji Damle - Innovative Inventor from Upper Saddle River

Introduction: Nitin Krishnaji Damle is a renowned inventor hailing from Upper Saddle River, New Jersey. His contributions to the field of innovation have been significant and impactful.

Latest Patents: Nitin Krishnaji Damle holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: Throughout his career, Nitin Krishnaji Damle has demonstrated a keen ability to identify gaps in existing technologies and develop novel inventions to address them. His innovative spirit has led to the creation of groundbreaking solutions that have improved efficiency and effectiveness in multiple industries.

Collaborations: Nitin Krishnaji Damle has collaborated with leading research institutions, universities, and companies to further his inventions and bring them to market. His partnerships have been instrumental in turning his ideas into tangible products that benefit society.

Conclusion: Nitin Krishnaji Damle's passion for innovation and his dedication to pushing the boundaries of what is possible make him a standout figure in the world of inventors. His work continues to inspire future generations of innovators to think outside the box and create solutions that make a difference.

Profile summary based on public USPTO records.